Were we wrong about the role of psychiatric comorbidities in primary headache?

Pain

Volumn 146, Issue 1-2, 2009, Pages 11-12

  Smitherman, Todd A ^a   Penzien, Donald B ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; NEFAZODONE;

ANXIETY DISORDER; BEHAVIOR THERAPY; CHRONIC TENSION HEADACHE; COMORBIDITY; DEPRESSION; DRUG INDUCED HEADACHE; EDITORIAL; HUMAN; MENTAL DISEASE; PRIMARY HEADACHE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TRANSFORMED MIGRAINE;

ANXIETY; DEPRESSION; HEADACHE DISORDERS, PRIMARY; HUMANS; MENTAL DISORDERS; MIGRAINE DISORDERS; TREATMENT OUTCOME;

EID: 70349972181     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.07.035     Document Type: Editorial

References (6)

1. Guidetti V., Galli F., Fabrizi P., Giannontoni A.S., Napoli L., Bruni O., and Trillo S. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 18 (1998) 455-462
2. Heckman B.D., and Holroyd K.A. Tension-type headache and psychiatric comorbidity. Curr Pain Headache Rep 10 (2006) 439-447
3. Heckman B.D., Holroyd K.A., Himawan L., O'Donnell F.J., Tietjen G., Utley C., and Stillman M. Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain 146 (2009) 56-64
4. Lantéri-Minet M., Radat F., Chautart M.H., and Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain 118 (2005) 319-326
5. Mitsikostas D.D., and Thomas A.M. Comorbidity of headache and depressive disorders. Cephalalgia 19 (1999) 211-217
6. Saper J.R., Lake AE I.I.I., and Tepper S.J. Nefazodone for chronic daily prophylaxis: an open-label study. Headache 41 (2001) 465-474